AstraZeneca sets 'Ambition Zero Carbon' plan to remove emissions by 2025
Category: #health  | By Mateen Dalal  | Date: 2022-03-28 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

AstraZeneca sets 'Ambition Zero Carbon' plan to remove emissions by 2025

AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, has recently recognized how important it is to push the limitations of science and provide life-changing medicines in record time.

The strong commitment to building a better and healthier future for all, including those staying in Thailand, is confirmed by supplying approximately 2.8 billion doses to about 180 countries and executing courageous initiatives in sustainability.

And in its support for decarbonization goals, AstraZeneca intends to ensure that 95% of its key suppliers and partners have science-based targets by the end of 2025.

To this end, it has made a brave commitment with its Ambition Zero Carbon strategy. This would enable the firm to aim for zero carbon emissions from the global operations and fleet by 2025 and become carbon negative by 2030 across the complete value chain.

Vice President and Head of Global Corporate Affairs, AstraZeneca, Sjoerd Hubben, said that the primary UK-listed biopharmaceutical firm plays a vital role in helping the community worldwide handle some of the biggest challenges the world is currently facing, precisely when it comes to climate change.

Mr. Hubben said that it is vital for firms like AstraZeneca to oblige more specifically to society's goals beyond delivering medicines. The firm intends to make a more significant contribution to the community.

He further added that the firm is helping its partners shift towards more sustainable solutions, including access to renewable energy.

AstraZeneca recognized how the health of people, the planet, and economies are interconnected. Hubben also notified that the climate crisis is causing a rise in chronic conditions like heart disease, stroke, respiratory diseases, and lung cancer. That is why everyone involved in delivering anything related to healthcare plays a crucial role in reducing emissions.

AstraZeneca is one of the seven global companies with net-zero targets verified by the SBTi (Science-Based Target Initiatives) in line with its New-Zero corporate standard. 

Source Credit - https://www.bangkokpost.com/business/2285194/astrazeneca-steps-up-to-tackle-climate-change

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

ChatGPT’s creator OpenAI proposes regulation of AI by humans

ChatGPT’s creator OpenAI proposes regulation of AI by humans

By Mateen Dalal

OpenAI, the creator of ChatGPT, has reportedly put forward a proposal for the establishment of an international organization to regulate artificial intelligence (AI). Led by CEO Sam Altman, the company believes that AI systems developed within the ne...

Medtronic pledges USD 350 Mn to expand R&D operations in India

Medtronic pledges USD 350 Mn to expand R&D operations in India

By Mateen Dalal

Medtronic, a leading healthcare technology company, has announced plans to expand its R&D center in Hyderabad, India, with a whopping investment of USD 350 million. The existing facility is already the largest center for the company outside the U...

DuPont to buy Spectrum Plastics, anticipates high ROIC by fifth year

DuPont to buy Spectrum Plastics, anticipates high ROIC by fifth year

By Mateen Dalal

American chemical company DuPont de Nemours Inc. reportedly signed a definitive agreement to buy out Spectrum Plastics Group from AEA Investors, a U.S. based private equity firm. The acquisition will reinforce DuPont’s position in booming non-c...